The Levels of Serum CXCL5，TLR4，and MMP-3 in Gouty Arthritis Patients with Different Clinical Features and Their Correlation with the Joint Destruction and Serum Uric Acid Levels

Xiaohua LI; Yalu FU; Dan WANG

Article Contents

Article Navigation > Journal of Kunming Medical University > 2025 > Uncorrected proof

Xiaohua LI, Yalu FU, Dan WANG. The Levels of Serum CXCL5，TLR4，and MMP-3 in Gouty Arthritis Patients with Different Clinical Features and Their Correlation with the Joint Destruction and Serum Uric Acid Levels[J]. Journal of Kunming Medical University.

Citation:

PDF( 991 KB)

The Levels of Serum CXCL5，TLR4，and MMP-3 in Gouty Arthritis Patients with Different Clinical Features and Their Correlation with the Joint Destruction and Serum Uric Acid Levels

1.
Rheumatism Diagnosis and Treatment Center of，Xi’an Shaanxi 710004
2.
Department of Rheumatology and Immunology，Xi’an Fifth Hospital，Xi’an Shaanxi 710003，China

Received Date: 2025-08-20
Available Online: 2025-11-01

Abstract

Abstract

Objective To analyze the correlation between serum levels of C-X-C motif chemokine 5 （CXCL5）, Toll-like receptor 4 （TLR4）, and matrix metalloproteinase-3 （MMP-3） with the degree of joint destruction and serum uric acid （SUA） levels in gouty arthritis patients with different clinical characteristics, and to evaluate their predictive value for severe GA. Methods A total of 212 GA patients （GA group） diagnosed at Xi'an People's Hospital between June 2023 and June 2025 were enrolled, along with 212 healthy individuals （control group）. Predictive value was assessed using receiver operating characteristic （ROC） curve analysis, and correlation was assessed using Pearson method. Results Serum levels of CXCL5, TLR4, and MMP-3 were significantly higher in the GA group compared to the control group （P < 0.05）. Statistically significant differences in serum levels of CXCL5, TLR4, and MMP-3 were observed among GA patients with different clinical stages, affected joints, presence of tophi, disease duration, and annual attack frequency （P < 0.05）. The severe GA group had higher levels of CXCL5, TLR4, and MMP-3 compared to the mild GA group （P < 0.05）. GA patients were at higher risk for severe disease when serum CXCL5, TLR4, and MMP-3 levels exceeded 612.56 pg/mL, 11.15 ng/mL, and 12.06 ng/mL, respectively. The combined prediction of severe GA by CXCL5, TLR4, and MMP-3 yielded an area under the curve （AUC） of 0.963. Compared to low-expression patients, those with high expression of CXCL5, TLR4, and MMP-3 had a 2.758-fold, 2.184-fold, and 2.227-fold increased risk of severe GA, respectively. CXCL5, TLR4, and MMP-3 were identified as influencing factors for the disease severity （P < 0.05）. The high SUA group had significantly higher serum levels of CXCL5, TLR4, and MMP-3 compared to the low SUA group （P < 0.05）. Conclusion GA patients exhibit high serum expression of CXCL5, TLR4, and MMP-3, which are significantly associated with clinical features, the degree of joint destruction, and SUA levels, demonstrating considerable clinical value.
- Gouty arthritis,
- Chemokine C-X-C motif ligand 5,
- Toll like receptor 4,
- Matrix metalloproteinase-3,
- Clinical features

FullText(HTML)

References(30)

References

[1]	Yao T K, Lee R P, Wu W T, et al. Advances in gouty arthritis management: Integration of established therapies, emerging treatments, and lifestyle interventions[J]. Int J Mol Sci, 2024, 25(19): 10853. doi: 10.3390/ijms251910853
[2]	Yin C, Lyu Q, Dong Z, et al. Well-defined alginate oligosaccharides ameliorate joint pain and inflammation in a mouse model of gouty arthritis[J]. Theranostics, 2024, 14(8): 3082-3103. doi: 10.7150/thno.95611
[3]	Hou Z, Ma A, Mao J, et al. Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout[J]. Expert Opin Drug Metab Toxicol, 2023, 19(12): 895-909. doi: 10.1080/17425255.2023.2287477
[4]	Chang T T, Li S Y, Tsai M T, et al. CXCL5 inhibition ameliorates acute kidney injury and prevents the progression from acute kidney injury to chronic kidney disease[J]. Clin Sci (Lond), 2024, 138(22): 1451-1466. doi: 10.1042/CS20241713
[5]	Brandolini L, Aramini A, Bianchini G, et al. Inflammation-independent antinociceptive effects of DF2755A, a CXCR1/2 selective inhibitor: A new potential therapeutic treatment for peripheral neuropathy associated to non-ulcerative interstitial cystitis/bladder pain syndrome[J]. Front Pharmacol, 2022, 13: 854238. doi: 10.3389/fphar.2022.854238
[6]	Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling[J]. Cell Mol Life Sci, 2021, 78(4): 1233-1261. doi: 10.1007/s00018-020-03656-y
[7]	Shi B, Guo X, Iv A, et al. Polymorphism of MMP-3 gene and imbalance expression of MMP-3/TIMP-1 in articular cartilage are associated with an endemic osteochondropathy, Kashin- Beck disease[J]. BMC Musculoskelet Disord, 2022, 23(1): 3. doi: 10.1186/s12891-021-04952-9
[8]	中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 痛风及高尿酸血症基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2020, 19(4): 293-303.
[9]	邵苗, 张学武. 2015年欧洲抗风湿病联盟/美国风湿病学会痛风分类新标准[J]. 中华风湿病学杂志, 2015, 19(12): 854-855
[10]	van der Heijde D. How to read radiographs according to the sharp/van der heijde method[J]. J Rheumatol, 2000, 27(1): 261-263.
[11]	Dalbeth N, Doyle A J. Imaging tools to measure treatment response in gout[J]. Rheumatology (Oxford), 2018, 57(suppl 1): i27-i34.
[12]	Keller S F, Mandell B F. Management and cure of gouty arthritis[J]. Med Clin North Am, 2021, 105(2): 297-310. doi: 10.1016/j.mcna.2020.09.013
[13]	Metzemaekers M, Mortier A, Vacchini A, et al. Endogenous modification of the chemoattractant CXCL5 alters receptor usage and enhances its activity toward neutrophils and monocytes[J]. Sci Signal, 2021, 14(673): eaax3053. doi: 10.1126/scisignal.aax3053
[14]	Park S E, Park K, Kim E, et al. CXCL5/CXCL8 induces neutrophilic inflammation in peri-implantitis[J]. J Periodontal Res, 2024, 59(4): 698-711. doi: 10.1111/jre.13230
[15]	Liang Y, Li H, Li J, et al. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an in vivo hACE2 transfection mouse model[J]. Zool Res, 2020, 41(6): 621-631. doi: 10.24272/j.issn.2095-8137.2020.118
[16]	Li C, Huang Y, Wu C, et al. Astilbin inhibited neutrophil extracellular traps in gouty arthritis through suppression of purinergic P2Y6 receptor[J]. Phytomedicine, 2024, 130: 155754. doi: 10.1016/j.phymed.2024.155754
[17]	Yin C, Liu B, Dong Z, et al. CXCL5 activates CXCR2 in nociceptive sensory neurons to drive joint pain and inflammation in experimental gouty arthritis[J]. Nat Commun, 2024, 15(1): 3263. doi: 10.1038/s41467-024-47640-7
[18]	冼英, 符洪明. 痛风性关节炎患者血清同型半胱氨酸、补体C3水平及其与尿酸的相关性[J]. 中外医学研究, 2023, 21(22): 71-73.
[19]	Silva C R, Saraiva A L, Rossato M F, et al. What do we know about toll-like receptors involvement in gout arthritis?[J]. Endocr Metab Immune Disord Drug Targets, 2023, 23(4): 446-457. doi: 10.2174/1871530322666220523145728
[20]	Liu L, He S, Jia L, et al. Correlation analysis of serum TLR4 protein levels and TLR4 gene polymorphisms in gouty arthritis patients[J]. PLoS One, 2024, 19(4): e0300582. doi: 10.1371/journal.pone.0300582
[21]	Lin S K, Chen S T, Zhan Y, et al. The alleviatory effects of koumine on MSU-induced gouty arthritis via the TLR4/NF-κB/NLRP3 pathway[J]. Basic Clin Pharmacol Toxicol, 2024, 135(2): 133-147. doi: 10.1111/bcpt.14037
[22]	Li Z, Yu Y, Sun Q, et al. Based on the TLR4/NLRP3 pathway and its impact on the formation of NETs to explore the mechanism of ginsenoside Rg₁ on acute gouty arthritis[J]. Int J Mol Sci, 2025, 26(9): 4233. doi: 10.3390/ijms26094233
[23]	Jeong J, Lim M K, Han E H, et al. Extract of Aster glehni ameliorates potassium oxonate-induced hyperuricemia by modulating renal urate transporters and renal inflammation by suppressing TLR4/MyD88 signaling[J]. Food Sci Biotechnol, 2022, 31(13): 1729-1739. doi: 10.1007/s10068-022-01153-5
[24]	Ruan H, Zhu T, Wang T, et al. Quercetin modulates ferroptosis via the SIRT1/nrf-2/HO-1 pathway and attenuates cartilage destruction in an osteoarthritis rat model[J]. Int J Mol Sci, 2024, 25(13): 7461. doi: 10.3390/ijms25137461
[25]	Qin Y Y, Qin Z Y, Liang T, et al. Phellodendrine chloride alleviates gouty arthritis through IL-6/STAT3 signaling pathway[J]. Immunobiology, 2025, 230(4): 152918. doi: 10.1016/j.imbio.2025.152918
[26]	Shi L, Yuan Z, Liu J, et al. Modified Simiaowan prevents articular cartilage injury in experimental gouty arthritis by negative regulation of STAT3 pathway[J]. J Ethnopharmacol, 2021, 270: 113825. doi: 10.1016/j.jep.2021.113825
[27]	Zhuang H, Ren X, Jiang F, et al. Indole-3-propionic acid alleviates chondrocytes inflammation and osteoarthritis via the AhR/NF-κB axis[J]. Mol Med, 2023, 29(1): 17. doi: 10.1186/s10020-023-00614-9
[28]	Wu Y, Wang Y, Yuan W, et al. Changes in serum inflammatory factors in acute gouty arthritis patients treated using ultrashort wave combined with loxoprofen sodium[J]. Pak J Med Sci, 2021, 37(7): 1788-1794.
[29]	Shi L, Liang T, Yang F, et al. Matrix Metalloproteinase-3 induces proteoglycan degradation in gouty arthritis model[J]. Gene, 2021, 765: 145120. doi: 10.1016/j.gene.2020.145120
[30]	Bourmaud M, Zarka M, Le Cozannet R, et al. Effect of Rubus idaeus extracts in murine chondrocytes and explants[J]. Biomolecules, 2021, 11(2): 245. doi: 10.3390/biom11020245

Relative Articles(20)

Relative Articles

[1]	Minhui ZHANG, Weidan YIN, Zhulin HU, Hua LI, Liwei ZHANG, Yuling REN. Clinical Features and Prognosis of Acute Macular Neuroretinopathy Associated with Novel Coronavirus Infection. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20250412
[2]	Jianfang MA, Xiaoling HUANG, Yanhua LI, Di MA, Kaifen YUAN. Analysis of Clinical Characteristics and Death Risk Factors in Patients with Community-acquired Pneumonia Complicated with Diabetes. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20240217
[3]	Jingshan CHEN, Li LI, Shili SHANG, Guoyong HE, Wenjing ZHOU, Sha LI, Di ZHANG, Yonglan LIU, Jun LI. Correlation Analysis between Pathological Features of IgA Nephropathy and Dyslipidemia. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20230111
[4]	Zhengqin GENG, Lin XIE, Hongli SONG, Rong LI, Yedan LIAO, Xueqi ZhANG, Jiadai TANG. Clinical Features and Related Prognostic Factors of 88 Cases of Duodenal Adenocarcinoma. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20220109
[5]	Weijie LI, Liqin CHEN, Yaling LI, Yonghui HAN, Xiaojuan LI, Fendong YAN. Epidemiology, Clinical Characteristics and Risk Factors of 148 Severe Pertussis Cases in Yunnan. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20220824
[6]	Weimin LU, Xiaotao YANG, Ying ZHU, Yi HUANG, Houyu CHEN, Haifeng JIN, Yanchun WANG. Clinical Features and Risk Factors for Critical Cases of Scrub Typhus in 175 Children. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20220814
[7]	Zhiying LU, Meifen WANG, Junchao PENG, Zengqing DU, Yunjiao LUO, Wei MA. Comparison of Serum PCT, IL-6, SAA Levels and Clinical Characteristics between Rotavirus and Norovirus Enteritis in Children. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20220823
[8]	Bo TIAN, Yinzhong SHEN, Jinsong BAI, Jun LIU, Haiyun CHEN, Jianjun SUN. Clinical Characteristics of Talaromyces Marneffei Disease and Disseminated Nontuberculosis Mycobacterium Disease in AIDS Patients. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20220718
[9]	Zhi-peng YU, Ai-ran DONG, Jing ZHANG, Fang WU, Ming-jie GAO, Jian CHEN, Hong CHANG, Li-yong WU. Clinical Characteristics of Acute Ischemic Stroke Based on Multiple Imaging Evaluation. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20211039
[10]	Yong-ji FU, Fei PENG, Mei GUO, Hua YAN, Qing-cheng SHEN, Jin-xi BAI, Liu YANG. Clinical Characteristics of Gastric Cancer in Young Patients: A Retrospective Cohort Study. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20210515
[11]	Jin-rong YANG, Kun WU, Bo NIE, Zhen-xin HE, Yu-yu YANG, Jie SUN, Yun ZENG. Clinical Features of Adult HPS and the Correlation between Cytokine Levels and Prognosis. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20211220
[12]	Hui-bo YANG, Qin MIAO, De-liang LIU, Si-si LI. Clinical Study on Characteristics of Kawasaki Disease in Yunnan Province. Journal of Kunming Medical University, doi: 10.12259/j.issn.2095-610X.S20201121
[13]	Dong Wei , Yuan Xiao Lin , Li Jiao , Li Zheng Yan , Liu Wei Tong , Yu Xiao Ling , Zhang Ying . The Research of Effects of Applying Cataplasm of Paris Polyphylla Smith Var. Yunnanensis (Franch.) Hand.-Mazz on Acute Gouty Arthritis and Inflammation. Journal of Kunming Medical University,
[14]	Yang Ke , Dan Zu Jian , Zhou Qiong Hua , Wang Jun Feng . Relationship between Soluble Cytokine Receptors, Matrix Metalloproteinases and Pancreatic Cancer. Journal of Kunming Medical University,
[15]	Shen Wen . Analysis of Clinical Characteristics and Misdiagnosis of 178 Patients with Pulmonary Embolism. Journal of Kunming Medical University,
[16]	Li Yan Ping . The Clinical Characteristics of Patients with Chronic Heart Failure with Preserved Ejection Fraction. Journal of Kunming Medical University,
[17]	Yang Jing . . Journal of Kunming Medical University,
[18]	Zhou Hong . . Journal of Kunming Medical University,
[19]	Li Xian Li . . Journal of Kunming Medical University,
[20]	Cheng Hui Rong . . Journal of Kunming Medical University,